Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19

  • Raden Muhammad Ali Satria Universitas Airlangga
  • Resty Varia Tutupoho Universitas Airlangga
  • Djazuly Chalidyanto Universitas Airlangga


This study aimed to analyze comorbid diseases as a risk factor for death due to COVID-19 at Bhakti Dharma Husada Hospital Surabaya. This research method is an observational analytic study with a retrospective study design. The results showed that 358 patients were infected with COVID-19 and confirmed with nose and throat swabs. Sixty-six patients (18%) died from COVID-19. 60.6% were male (OR 1.87, P 0.041), 22.7% aged> 64 years (OR 2.097, P 0.041), and 83.3% of them were co-risk factors. Diabetes mellitus (30.3%) (OR 4,348, P 0,000), and cardiovascular disease (10.6%) (OR 4,319, P 0.016) were the highest risk factors for death in COVID-19. In conclusion, men, old age, diabetes, and hypertension are risk factors for death in COVID-19.

Keywords: COVID-19, Diabetes, Hypertension, Comorbid, Elderly, Mortality


Aggarwal, G., Henry, B. ., Aggarwal, S., & Bangalore, S. (2020). Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. American Journal of Cardiology, 128, 147–150.

Alharbi, Y., Alqahtani, A., Albalawi, O., & Bakouri, M. (2020). Epidemiological Modeling of COVID-19 in Saudi Arabia: Spread projection, awareness, and impact of treatment. Applied Sciences (Switzerland), 10(17).

Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., & Wang, M. (2020). Presumed Asymptomatic Carrier Transmission of COVID-19. In JAMA - Journal of the American Medical Association (Vol. 323, Issue 14, pp. 1406–1407).

Chan, J. F. W., Yuan, S., Kok, K. H., To, K. K. W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C. Y., Poon, R. W. S., Tsoi, H. W., Lo, S. K. F., Chan, K. H., Poon, V. K. M., Chan, W. M., Ip, J. D., Cai, J. P., Cheng, V. C. C., Chen, H., & Yuen, K. Y. (2020). A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster. The Lancet, 395(10223), 514–523.

Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., Merson, L., Lee, J., Plotkin, D., Sigfrid, L., Halpin, S., Jackson, C., Gamble, C., Horby, P. W., Nguyen-Van-Tam, J. S., & Semple, M. G. (2020). Features of 16,749 Hospitalised UK Patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv, 2020.04.23.20076042.

Fang, Y., Zhang, H., Xie, J., Lin, M., Ying, L., Pang, P., & Ji, W. (2020). Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology, 200432.

Gorbalenya, A. E., Baker, S. C., Baric, R. S., Groot, R. J. De, Gulyaeva, A. A., Haagmans, B. L., Lauber, C., & Leontovich, A. M. (2020). Severe Acute Respiratory Syndrome-Related Coronavirus: The Species and Its Viruses – A Statement of the Coronavirus Study Group. Biorxiv (Cold Spring Harbor Laboratory), 1–15.

Han, Y., & Yang, H. (2020). The Transmission and Diagnosis of 2019 Novel Coronavirus Infection Disease (COVID-19): A Chinese Perspective. Journal of Medical Virology, 92(6), 639–644.

Ji, W., Wang, W., Zhao, X., Zai, J., & Li, X. (2020). Cross-Species Transmission of the Newly Identified Coronavirus 2019-nCoV. Journal of Medical Virology, 92(4), 433–440.

Longato, E., Fadini, G. P., Sparacino, G., Gubian, L., & Di Camillo, B. (2020). Prediction of Cardiovascular Complications in Diabetes from Pharmacy Administrative Claims. 20th IEEE Mediterranean Electrotechnical Conference, Melecon 2020 - Proceedings, 315–320.

Mantovani, A., Byrne, C. D., Zheng, M. H., & Targher, G. (2020). Diabetes as a Risk Factor for Greater COVID-19 Severity and in-Hospital Death: A Meta-Analysis of Observational Studies. Nutrition, Metabolism and Cardiovascular Diseases, 30(8), 1236–1248.

Moana, N. (2020). Konsep Isolasi dalam Jaringan Sosial untuk Meminimalisasi Efek Contagious (Kasus Penyebaran Virus Corona di Indonesia). Jurnal Sosial Humaniora Terapan, 2(2), 117–125.

Setiawan, A. R. (2020). Lembar Kegiatan Literasi Saintifik untuk Pembelajaran Jarak Jauh Topik Penyakit Coronavirus 2019 (COVID-19). Edukatif : Jurnal Ilmu Pendidikan, 2(1), 28–37.

The Lancet. (2020). The Gendered Dimensions of COVID-19. In The Lancet (Vol. 395, Issue 10231, p. 1168).

Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does Comorbidity Increase the Risk of Patients with Covid-19: Evidence from Meta-Analysis. Aging, 12(7), 6049–6057.

Wenham, C., Smith, J., & Morgan, R. (2020). COVID-19: the Gendered Impacts of the Outbreak. In The Lancet (Vol. 395, Issue 10227, pp. 846–848).

Yang, W., & Yan, F. (2020). Patients with RT-PCR-Confirmed COVID-19 and Normal Chest CT. Radiology, 41(1), 43–43.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727–733.

Zulva, T. N. I. (2019). Covid-19 Dan Kecenderungan Psikosomatis. Journal of Chemical Information and Modeling, 53(9), 1689–1699
How to Cite
Satria, R., Tutupoho, R., & Chalidyanto, D. (2020). Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19. Jurnal Keperawatan Silampari, 4(1), 48-55.
Abstract viewed = 745 times
pdf downloaded = 766 times